Table 3. Adjusted hazard ratio for overall survival in each treatment.
Best supportive care | Doublet chemotherapy | Metastasectomy | Doublet chemotherapy or Metastasectomy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | HR | 95% CI | p value | |
Differentiation | ||||||||||||
Wel/Mod | (reference) | (reference) | (reference) | (reference) | ||||||||
Por/Muc/Sig | 1.02 | (0.66–1.60) | 0.91 | 1.48 | (1.05–2.07) | 0.023 | 2.25 | (0.92–5.54) | 0.077 | 1.51 | (1.10–2.06) | 0.011 |
Adjusted for age, sex, CCI, primary tumor site, T-factor, N-factor, liver metastasis, lung metastasis, peritoneal dissemination, distal lymph node metastasis, other-organ metastasis, and the number of organs with metastasis.
Abbreviations: HR = hazard ratio.